These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 26758850)
1. Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity. Yuan P; Grutzendler J J Neurosci; 2016 Jan; 36(2):632-41. PubMed ID: 26758850 [TBL] [Abstract][Full Text] [Related]
2. K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice. Zhang YH; Mann D; Raymick J; Sarkar S; Paule MG; Lahiri DK; Dumas M; Bell-Cohen A; Schmued LC Curr Alzheimer Res; 2014 Mar; 11(3):299-308. PubMed ID: 24552157 [TBL] [Abstract][Full Text] [Related]
3. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
4. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis. Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325 [TBL] [Abstract][Full Text] [Related]
5. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
6. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570 [TBL] [Abstract][Full Text] [Related]
7. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum. Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710 [TBL] [Abstract][Full Text] [Related]
8. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease. Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020 [TBL] [Abstract][Full Text] [Related]
9. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease. Paouri E; Tzara O; Zenelak S; Georgopoulos S J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177 [TBL] [Abstract][Full Text] [Related]
10. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model. Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586 [No Abstract] [Full Text] [Related]
11. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. van Groen T; Liu L; Ikonen S; Kadish I Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872 [TBL] [Abstract][Full Text] [Related]
12. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice. Zhao G; Liu HL; Zhang H; Tong XJ Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model. Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083 [TBL] [Abstract][Full Text] [Related]
15. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing. Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851 [TBL] [Abstract][Full Text] [Related]
16. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation. Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770 [TBL] [Abstract][Full Text] [Related]
17. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Lauretti E; Craige CP; Praticò D J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099 [TBL] [Abstract][Full Text] [Related]
19. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Choi Y; Jeong HJ; Liu QF; Oh ST; Koo BS; Kim Y; Chung IW; Kim YS; Jeon S Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]